{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:47:16Z","timestamp":1782870436232,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To evaluate the safety and outcomes of primary orbital implantation during evisceration\/enucleation for endophthalmitis, specifically analyzing the risk of implant exposure\/extrusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective review of 98 endophthalmitis patients (90 eviscerations, 8 enucleations) who received a primary orbital implant (mostly PMMA) over 10 years. Follow-up averaged 27.5 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Postoperative implant exposure\/extrusion occurred in 10 patients (10.2%). This rate is comparable to established literature. The mean time to exposure was 140 days. Neither preoperative orbital cellulitis nor culture positivity (e.g.,\n                      <jats:italic>Pseudomonas<\/jats:italic>\n                      ) was statistically associated with a higher risk of exposure. Re-operations for exposure did not show evidence of active, ongoing infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Primary orbital implantation in endophthalmitis patients is safe, carrying an exposure\/extrusion risk (10.2%) comparable to reported rates. The procedure should be favored over a two-staged approach unless significant inflammation is noted intraoperatively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Pr\u00e9cis<\/jats:title>\n                    <jats:p>The purpose of this paper is to study outcomes of primary orbital implantation in Endophthalmitis patient, and to review the exposure rate, and to also analyze possible risk factors for the exposure\/extrusion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-026-04871-0","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T19:18:18Z","timestamp":1778181498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of primary orbital implantation in evisceration\/enucleation in patients with endophthalmitis in a tertiary hospital"],"prefix":"10.1186","volume":"26","author":[{"given":"Saleh","family":"Alrashed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maram","family":"Alnefaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawan N.","family":"Althaqib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamad M.","family":"Alsulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"4871_CR1","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/00055735-200210000-00002","volume":"13","author":"ME Migliori","year":"2002","unstructured":"Migliori ME. Enucleation versus evisceration. Curr Opin Ophthalmol. 2002;13:298\u2013302.","journal-title":"Curr Opin Ophthalmol"},{"key":"4871_CR2","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1001\/archopht.1988.01060140463053","volume":"106","author":"JW Shore","year":"1988","unstructured":"Shore JW, Dieckert P, J. P., Levine MR. Delayed Primary Wound Closure: Use to Prevent Implant Extrusion Following Evisceration for Endophthalmitis. Arch Ophthalmol. 1988;106:1303\u20138.","journal-title":"Arch Ophthalmol"},{"key":"4871_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/00002341-198501040-00005","volume":"1","author":"WL Walter","year":"1985","unstructured":"Walter WL. Update on enucleation and evisceration surgery. Ophthal Plast Reconstr Surg. 1985;1:243\u201352.","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"4871_CR4","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1136\/bjo.2006.103937","volume":"91","author":"P Viswanathan","year":"2007","unstructured":"Viswanathan P, Sagoo MS, Olver JM. UK national survey of enucleation, evisceration and orbital implant trends. Br J Ophthalmol. 2007;91:616\u20139.","journal-title":"Br J Ophthalmol"},{"key":"4871_CR5","first-page":"315","volume":"37","author":"R Fu","year":"2018","unstructured":"Fu R, Childs J, Nunery W, Timoney P. Surgical preferences in the management of recalcitrant endophthalmitis. Orbit (London). 2018;37:315\u201320.","journal-title":"Orbit (London)"},{"key":"4871_CR6","first-page":"568","volume":"103","author":"a Comparison of Implant Extrusion","year":"2005","unstructured":"a Comparison of Implant Extrusion. Rates and Postoperative Pain After. Trans Am Ophthalmol Soc. 2005;103:568\u201391.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"4871_CR7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/01.IOP.0000159174.80985.E2","volume":"21","author":"AD Abel","year":"2005","unstructured":"Abel AD, Meyer DR. Enucleation with primary implant insertion for treatment of recalcitrant endophthalmitis and panophthalmitis. Ophthal Plast Reconstr Surg. 2005;21:220\u20134.","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"4871_CR8","doi-asserted-by":"crossref","unstructured":"Tawfik HA, Budin H. Evisceration with primary implant placement in patients with endophthalmitis. Ophthalmology. 2007:114.","DOI":"10.1016\/j.ophtha.2006.09.027"},{"key":"4871_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3341\/kjo.2010.24.5.279","volume":"24","author":"YG Park","year":"2010","unstructured":"Park YG, Paik JS, Yang SW. The results of evisceration with primary porous implant placement in patients with endophthalmitis. Korean J Ophthalmol. 2010;24:279\u201383.","journal-title":"Korean J Ophthalmol"},{"key":"4871_CR10","first-page":"279","volume":"34","author":"D Tripathy","year":"2015","unstructured":"Tripathy D, Rath S. Evisceration with Primary Orbital Implant in Fulminant Endophthalmitis\/Panophthalmitis. Orbit (London). 2015;34:279\u201383.","journal-title":"Orbit (London)"},{"key":"4871_CR11","first-page":"1","volume":"10","author":"JM Kim","year":"2021","unstructured":"Kim JM, Sung JY, Lim H, Bin, Choi EJ, Lee SB. Risk factors for orbital implant extrusion after evisceration. J Clin Med. 2021;10:1\u20138.","journal-title":"J Clin Med"},{"key":"4871_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/ojo.OJO_156_2016","volume":"10","author":"HA Al-Farsi","year":"2017","unstructured":"Al-Farsi HA, Sabt B, Al-Mujaini A. Orbital implant exposure following enucleation or evisceration. Oman J Ophthalmol. 2017;10:87\u201390.","journal-title":"Oman J Ophthalmol"},{"key":"4871_CR13","doi-asserted-by":"publisher","first-page":"126","DOI":"10.18231\/j.ijooo.2023.028","volume":"9","author":"SMU Kadir","year":"2023","unstructured":"Kadir SMU, et al. Evisceration with primary orbital implant in endophthalmitis\/ panophthalmitis. IP Int J Ocul Oncol Oculoplasty. 2023;9:126\u201332.","journal-title":"IP Int J Ocul Oncol Oculoplasty"},{"key":"4871_CR14","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1038\/s41433-020-01382-0","volume":"35","author":"SJ Chiu","year":"2021","unstructured":"Chiu SJ, Tan JHY, Currie Z. I. To implant or not to implant: emergency orbital eviscerations with primary orbital implants. Eye. 2021;35:3077\u201386.","journal-title":"Eye"},{"key":"4871_CR15","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/S0161-6420(00)00262-1","volume":"107","author":"SC Dresner","year":"2000","unstructured":"Dresner SC, Karesh JW. Primary implant placement with evisceration in patients with endophthalmitis. Ophthalmology. 2000;107:1661\u20134.","journal-title":"Ophthalmology"},{"key":"4871_CR16","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.ajo.2006.11.029","volume":"143","author":"OR Ozgur","year":"2007","unstructured":"Ozgur OR, Akcay L, Dogan OK. Primary implant placement with evisceration in patients with endophthalmitis. Am J Ophthalmol. 2007;143:902\u20134.","journal-title":"Am J Ophthalmol"},{"key":"4871_CR17","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S0181-5512(05)81105-2","volume":"28","author":"M-C Gaillard","year":"2005","unstructured":"Gaillard M-C, Gianoli F, Spahn B. [Evisceration and secondary enucleation with implantation following endophthalmitis]. J Fr Ophtalmol. 2005;28:618\u201322.","journal-title":"J Fr Ophtalmol"},{"key":"4871_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/IOP.0000000000000212","volume":"31","author":"FM Quaranta-Leoni","year":"2015","unstructured":"Quaranta-Leoni FM, Sposato S, Lorenzano D. Secondary orbital ball implants after enucleation and evisceration: Surgical management, morbidity, and long-term outcome. Ophthal Plast Reconstr Surg. 2015;31:115\u20138.","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"4871_CR19","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/s41433-022-02135-x","volume":"37","author":"KKH Lai","year":"2023","unstructured":"Lai KKH, et al. Surgical outcomes of orbital evisceration with primary orbital implant placement in patients with endophthalmitis. Eye. 2023;37:1361\u20134.","journal-title":"Eye"},{"key":"4871_CR20","unstructured":"Wongsaithong M, Chokesuwattanaskul S. Predisposing factors and timing of orbital implant exposure \/ extrusion following enucleation or evisceration: an 11-year study. 2023;37:51\u20139."},{"key":"4871_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/09286580600943598","volume":"14","author":"IA Chaudhry","year":"2007","unstructured":"Chaudhry IA, Alkuraya HS, Shamsi FA, Elzaridi E, Riley FC. Current indications and resultant complications of evisceration. Ophthalmic Epidemiol. 2007;14:93\u20137.","journal-title":"Ophthalmic Epidemiol"},{"key":"4871_CR22","first-page":"1884","volume":"8","author":"PH Mules","year":"1990","unstructured":"Mules PH. Evisceration of the globe with artificial vitreous. Adv Ophthalmic Plast Reconstr Surg. 1990;8:1884\u201395.","journal-title":"Adv Ophthalmic Plast Reconstr Surg"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-04871-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04871-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04871-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:07:41Z","timestamp":1782868061000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-04871-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4871"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-04871-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9187686\/v1","asserted-by":"object"}]},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"21 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethical approval from the Research Council and the Human Investigation Committee of King Khalid Eye Specialist Hospital, Riyadh, Saudi Arabia and in accordance with the Declaration of Helsinki. The requirement for informed consent was waived for all adult patients and for the parents\/legal guardians of pediatric patients after thorough explanation of the study procedures by the Research Council and the Human Investigation Committee of King Khalid Eye Specialist Hospital, Riyadh, Saudi Arabia.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"363"}}